Published in J Exp Med on June 01, 1995
B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med (1999) 4.52
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol (2012) 3.69
Identification and characterization of circulating human transitional B cells. Blood (2005) 3.62
BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med (2000) 3.43
Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest (2005) 2.55
Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci U S A (1998) 2.08
Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol (2009) 2.05
Burkitt lymphoma in the mouse. J Exp Med (2000) 1.96
Characterization of marginal zone B cell precursors. J Exp Med (2005) 1.92
Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood (2010) 1.79
Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev (2011) 1.70
BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med (2005) 1.67
Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med (2008) 1.55
Receptor selection in B and T lymphocytes. Annu Rev Immunol (2000) 1.49
Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J Exp Med (1997) 1.46
Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med (1997) 1.41
Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med (2000) 1.41
Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc Natl Acad Sci U S A (1997) 1.33
B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis. J Clin Immunol (2009) 1.26
Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome. J Immunol (2009) 1.22
Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes. Clin Exp Immunol (2012) 1.21
Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med (2012) 1.19
Regulation of the B cell receptor repertoire and self-reactivity by BAFF. J Immunol (2010) 1.19
Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med (1999) 1.18
Dlk1 influences differentiation and function of B lymphocytes. Stem Cells Dev (2008) 1.17
POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function. Immunol Rev (2012) 1.14
Antigen-independent appearance of recombination activating gene (RAG)-positive bone marrow B cells in the spleens of immunized mice. J Exp Med (2000) 1.12
Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J Exp Med (1996) 1.10
Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM. J Immunol (2011) 1.08
Regulation of B-cell entry into the cell cycle. Immunol Rev (2008) 1.06
Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity (2007) 1.06
New insights into the enigma of immunoglobulin D. Immunol Rev (2010) 1.06
B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol (2004) 1.05
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat Med (2015) 1.04
Different sensitivity to receptor editing of B cells from mice hemizygous or homozygous for targeted Ig transgenes. Proc Natl Acad Sci U S A (2000) 1.01
Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol (2013) 1.01
Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J Exp Med (2002) 1.00
Rapid elimination of mature autoreactive B cells demonstrated by Cre-induced change in B cell antigen receptor specificity in vivo. Proc Natl Acad Sci U S A (1998) 1.00
The riddle of the dual expression of IgM and IgD. Immunology (2006) 0.99
Autocrine secretion of interferon gamma negatively regulates homing of immature B cells. J Exp Med (2000) 0.98
The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol Cell Biol (2001) 0.98
Reduced receptor editing in lupus-prone MRL/lpr mice. J Exp Med (2007) 0.96
A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells. Exp Hematol (2009) 0.95
The Ets factor Spi-B is a direct critical target of the coactivator OBF-1. Proc Natl Acad Sci U S A (2006) 0.94
The analysis of clonal expansions in normal and autoimmune B cell repertoires. Philos Trans R Soc Lond B Biol Sci (2015) 0.92
Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum (2009) 0.90
Effects of acute and chronic inflammation on B-cell development and differentiation. J Invest Dermatol (2009) 0.90
A fail-safe mechanism for negative selection of isotype-switched B cell precursors is regulated by the Fas/FasL pathway. J Exp Med (2003) 0.90
Immunological aspects in chronic lymphocytic leukemia (CLL) development. Ann Hematol (2012) 0.88
The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production. Mol Immunol (2011) 0.88
Resolve, revise, and relax: the 3 Rs of B cell repertoire adjustment. Immunol Lett (2012) 0.86
Liver-expressed Igkappa superantigen induces tolerance of polyclonal B cells by clonal deletion not kappa to lambda receptor editing. J Exp Med (2011) 0.85
Apoptotic marginal zone deletion of anti-Sm/ribonucleoprotein B cells. Proc Natl Acad Sci U S A (2012) 0.85
Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc Natl Acad Sci U S A (2007) 0.85
The role of the aryl hydrocarbon receptor in normal and malignant B cell development. Semin Immunopathol (2013) 0.84
Spontaneous loss of tolerance of autoreactive B cells in Act1-deficient rheumatoid factor transgenic mice. J Immunol (2013) 0.84
The function and regulation of immunoglobulin D. Curr Opin Immunol (2011) 0.84
Global analysis of B cell selection using an immunoglobulin light chain-mediated model of autoreactivity. J Exp Med (2012) 0.83
A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(-)CD24 (-) B cells in centenarian offspring and elderly people. Age (Dordr) (2012) 0.83
Translating transitions - how to decipher peripheral human B cell development. J Biomed Res (2015) 0.81
Somatically diversified and proliferating transitional B cells: implications for peripheral B cell homeostasis. J Immunol (2011) 0.81
Mechanisms of central tolerance for B cells. Nat Rev Immunol (2017) 0.81
Delayed cellular maturation and decreased immunoglobulin kappa light chain production in immature B lymphocytes lacking B cell linker protein. J Exp Med (2002) 0.80
Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. Eur J Immunol (2013) 0.79
B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel. Blood (2016) 0.79
Lyn deficiency affects B-cell maturation as well as survival. Eur J Immunol (2011) 0.79
Tyrosine 129 of the murine gammaherpesvirus M2 protein is critical for M2 function in vivo. PLoS One (2014) 0.78
Transitional B cell subsets in human bone marrow. Clin Exp Immunol (2013) 0.78
IL-7 sensitizes human pre-B cells but not pro-B cells to Fas/APO-1 (CD95)-mediated apoptosis. Clin Exp Immunol (1997) 0.77
Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency. Hum Gene Ther (2015) 0.77
A gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivo. PLoS Pathog (2014) 0.77
Toll-like receptor 4-mediated signaling regulates IL-7-driven proliferation and differentiation of B-cell precursors. Cell Mol Immunol (2013) 0.76
The absence of immunoglobulin D B cell receptor-mediated signals promotes the production of autoantibodies and exacerbates glomerulonephritis in murine lupus. Clin Exp Immunol (2011) 0.76
Positive selection of natural poly-reactive B cells in the periphery occurs independent of heavy chain allelic inclusion. PLoS One (2015) 0.75
B Cell Development in the Bone Marrow Is Regulated by Homeostatic Feedback Exerted by Mature B Cells. Front Immunol (2016) 0.75
B Cell Anomalies in Autoimmune Retinopathy (AIR). Invest Ophthalmol Vis Sci (2017) 0.75
Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells. J Immunol (2017) 0.75
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods (1991) 16.64
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell (1993) 14.39
Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med (1991) 10.87
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell (1991) 8.27
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell (1991) 8.13
Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J (1984) 6.67
Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science (1993) 5.50
Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science (1993) 4.08
Cellular mechanisms of immunologic tolerance. Annu Rev Immunol (1983) 4.07
Most peripheral B cells in mice are ligand selected. J Exp Med (1991) 3.50
Checkpoints of dueling dimers foil death wishes. Cell (1994) 3.45
Immunoglobulin-receptors revisited. Science (1975) 3.38
bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development (1994) 3.34
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell (1993) 3.07
Selective events in T cell development. Annu Rev Immunol (1994) 3.01
Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J Immunol (1993) 2.86
Antigen receptors on B lymphocytes. Annu Rev Immunol (1992) 2.65
Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol (1993) 2.50
Activation of V kappa gene rearrangement in pre-B cells follows the expression of membrane-bound immunoglobulin heavy chains. EMBO J (1987) 2.31
Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol (1992) 2.15
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Transmission and expression of a specific pair of rearranged immunoglobulin mu and kappa genes in a transgenic mouse line. Nature (1985) 2.08
The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J (1994) 1.94
Population dynamics of bone marrow B lymphocytes. Immunol Rev (1986) 1.94
Biased expression of JH-proximal VH genes occurs in the newly generated repertoire of neonatal and adult mice. J Exp Med (1990) 1.91
Peripheral B cell maturation. I. Immature peripheral B cells in adults are heat-stable antigenhi and exhibit unique signaling characteristics. J Immunol (1992) 1.77
The surrogate light chain in B-cell development. Immunol Today (1993) 1.64
The turnover of B-cell populations. Immunol Today (1993) 1.40
APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol (1993) 1.39
Differentiation of growth signal requirement of B lymphocyte precursor is directed by expression of immunoglobulin. EMBO J (1991) 1.38
Transmembrane signals and intracellular "second messengers" in the regulation of quiescent B-lymphocyte activation. Immunol Rev (1987) 1.32
mIgM:mIgD ratios on B cells: mean mIgD expression exceeds mIgM by 10-fold on most splenic B cells. J Immunol (1984) 1.17
Roles of IgH and L chains and of surrogate H and L chains in the development of cells of the B lymphocyte lineage. Annu Rev Immunol (1994) 1.15
Selection of VH gene repertoires: differentiating B cells of adult bone marrow mimic fetal development. Int Immunol (1990) 1.14
A role for immunoglobulin D: interference with tolerance induction. Eur J Immunol (1993) 0.99
Signalling in B cells. Immunol Today (1991) 0.98
The Fas/APO-1 receptor and its deadly ligand. Trends Cell Biol (1994) 0.96
Expression of prohibitin, an antiproliferative protein. Exp Gerontol (1993) 0.94
An in situ study of B-lymphocytopoiesis in rat bone marrow. Topographical arrangement of terminal deoxynucleotidyl transferase-positive cells and pre-B cells. J Immunol (1989) 0.94
Immune status of a mu, kappa transgenic mouse line. Deficient response to bacterially related antigens. Eur J Immunol (1989) 0.90
In rat B lymphocyte genesis sixty percent is lost from the bone marrow at the transition of nondividing pre-B cell to sIgM+ B lymphocyte, the stage of Ig light chain gene expression. Eur J Immunol (1990) 0.84
Mechanisms and meaning of B-lymphocyte tolerance. Res Immunol (1992) 0.83
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol (1976) 30.70
A better cell line for making hybridomas secreting specific antibodies. Nature (1978) 15.13
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur J Immunol (1976) 7.64
Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (1993) 6.54
B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med (1999) 4.52
Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein. J Cell Biol (1987) 3.33
Consequences of frameshift mutations at the immunoglobulin heavy chain locus of the mouse. EMBO J (1985) 3.25
IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity (1996) 3.23
Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol (1999) 2.77
Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun (1998) 2.60
CD22 is a negative regulator of B-cell receptor signalling. Curr Biol (1997) 2.37
Deletions in immunoglobulin mu chains. EMBO J (1982) 2.35
Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J Immunol (1999) 2.33
Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res (1996) 2.23
Transmission and expression of a specific pair of rearranged immunoglobulin mu and kappa genes in a transgenic mouse line. Nature (1985) 2.08
IL-4-deficient Balb/c mice resist infection with Leishmania major. J Exp Med (1996) 2.03
Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc Natl Acad Sci U S A (1983) 2.03
The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J (1994) 1.94
Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells. Nat Med (1999) 1.93
Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun (1998) 1.89
Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol (1997) 1.87
A differentially expressed murine RNA encoding a protein with similarities to two types of nucleic acid binding motifs. Nucleic Acids Res (1991) 1.86
Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. J Immunol (2005) 1.80
Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptor-deficient mice. J Immunol (1997) 1.76
Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med (1995) 1.71
The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol (1994) 1.63
Monoclonal antibodies specific for murine IgM I. Characterization of antigenic determinants on the four constant domains of the mu heavy chain. Eur J Immunol (1984) 1.58
Mutations affecting the structure and function of immunoglobulin M. Mol Cell Biol (1982) 1.58
Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. Br J Rheumatol (1998) 1.56
Immunoglobulin production by lymphocyte hybridomas. Eur J Immunol (1978) 1.56
Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol Microbiol (1999) 1.51
Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med (1995) 1.49
An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol (1997) 1.46
Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Bacteriol (2000) 1.45
Immunoglobulin chain loss in hybridoma lines. Proc Natl Acad Sci U S A (1980) 1.44
Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood (1997) 1.44
Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect Immun (2000) 1.42
Negative feedback regulation of IgE synthesis by murine CD23. Nature (1994) 1.42
Immunohistochemical analysis on potential new molecular targets for esophageal cancer. Dis Esophagus (2013) 1.41
IgM antibodies induce the production of antibodies of the same specificity. Proc Natl Acad Sci U S A (1980) 1.40
IgD can largely substitute for loss of IgM function in B cells. Nature (1998) 1.36
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int J Cancer (2000) 1.32
IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol (2000) 1.30
Effect of transmembrane and cytoplasmic domains of IgE on the IgE response. Science (1997) 1.26
Two new proteins preferentially associated with membrane immunoglobulin D. EMBO J (1994) 1.25
Comparison of four methods for early detection of experimental Trichinella spiralis infections in pigs. Vet Parasitol (1981) 1.21
Evolution of microbial pathogens. Philos Trans R Soc Lond B Biol Sci (2000) 1.20
Derivation of hybrids between a thymoma line and spleen cells activated in a mixed leukocyte reaction. Eur J Immunol (1977) 1.19
Somatic cell genetics of antibody-secreting cells: studies of clonal diversification and analysis by cell fusion. Cold Spring Harb Symp Quant Biol (1977) 1.18
IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int Immunol (1999) 1.18
Spontaneous esophagotracheal fistula resulting from ulcer in heterotopic gastric mucosa. Gastroenterology (1988) 1.17
Expression of immunoglobulin delta chain causes allelic exclusion in transgenic mice. Nature (1988) 1.15
Monoclonal anti-Fc IgG receptor antibodies trigger B lymphocyte function. Nature (1982) 1.12
Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Vaccine (2001) 1.12
IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J Immunol (1999) 1.12
Abnormal bone marrow stroma in mice deficient for nemo-like kinase, Nlk. Eur J Immunol (2001) 1.10
Antigen-antibody complexes bound to B-lymphocyte Fc gamma receptors regulate B-lymphocyte differentiation. Cell Immunol (1985) 1.08
IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18. J Immunol (2001) 1.08
Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. Ann N Y Acad Sci (1995) 1.08
Dissociation of DNA/anti-DNA complexes at high pH. Immunol Commun (1980) 1.07
Frequency of precursor cells against the enzyme beta-galactosidase: an estimate of the BALB/c strain antibody repertoire. Eur J Immunol (1976) 1.04
Fusion of T and B cells. Somatic Cell Genet (1977) 1.03
Cellular and molecular restrictions of the lymphocyte fusion. Curr Top Microbiol Immunol (1978) 1.02
Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells. Biol Chem (2000) 1.02
Epiglottic tuberculosis: differential diagnosis and treatment. Case report and review of the literature. Ann Otol Rhinol Laryngol (2001) 1.01
Immunoglobulin mu and gamma heavy chain classes are not determined by class-specific RNA-splicing enzymes. Nature (1978) 1.00
Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc Natl Acad Sci U S A (1993) 1.00
Biological activities of antitrinitrophenyl and antidinitrophenyl mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 1.00
Roles of protein and carbohydrate in glycoprotein processing and secretion. Studies using mutants expressing altered IgM mu chains. J Biol Chem (1981) 0.99
Derivation and diversification of monoclonal antibodies. EMBO J (1985) 0.99
Cloning and sequencing of mouse ribosomal protein S12 cDNA. Nucleic Acids Res (1989) 0.99
What makes a shock wave efficient in lithotripsy? J Stone Dis (1992) 0.99
A role for immunoglobulin D: interference with tolerance induction. Eur J Immunol (1993) 0.99
Molecular requirements for the mu-induced light chain gene rearrangement in pre-B cells. EMBO J (1991) 0.98
Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up. Diabetologia (2004) 0.98
B cell tolerance in mice transgenic for anti-CD8 immunoglobulin mu chain. J Exp Med (1991) 0.98
Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am J Respir Crit Care Med (2000) 0.98
The molecular interactions with helper T cells which limit antigen-specific B cell differentiation. Eur J Immunol (1988) 0.96
Characterization of a reovirus isolate from a rattle snake, Crotalus viridis, with neurological dysfunction. Arch Virol (1994) 0.96
[Immune biological research on rabbits with ixodide infestation]. Berl Munch Tierarztl Wochenschr (1967) 0.95
Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes. I. Assay conditions, quantitative aspects and differences between human blood monocytes and neutrophils. Eur J Immunol (1981) 0.94
Quick nested PCR screening of ES cell clones for gene targeting events. Biotechniques (1993) 0.93
Elimination of CD8+ thymocytes in transgenic mice expressing an anti-Lyt2.2 immunoglobulin heavy chain gene. EMBO J (1989) 0.92
The genes for a mouse hematopoietic differentiation marker called the heat-stable antigen. Eur J Immunol (1991) 0.92
Cyclic AMP inhibits contractility of detergent treated glycerol extracted cardiac muscle. Pflugers Arch (1981) 0.92
The heat stable antigen (mouse CD24) gene is differentially regulated but has a housekeeping promoter. J Biol Chem (1993) 0.91
B-cell maturation in chimaeric mice deficient for the heat stable antigen (HSA/mouse CD24). Transgenic Res (1995) 0.91